PROSPECT: Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial

前景：益生菌预防重症肺炎和气管内定植试验

• 批准号: 343844
• 负责人: Johnstone Jennie
• 金额: $ 92.73万
• 依托单位: Public Health Ontario (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-03-01 至 2019-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=343844&lang=en
• 关键词: Clostridium Difficile; Critically Ill; Diarrhea; Infection; Intensive Care Unit; Pneumonia; Probiotics; Randomized Controlled Trial

Probiotics are commercially available live bacteria thought to have health benefits when ingested. Studies have shown that probiotics may prevent 25% of all pneumonias when patients are on a breathing machine, 18% of all other infections, and 65% of seri

益生菌是市售的活细菌，被认为摄入后对健康有益。 研究表明，当患者使用呼吸机时，益生菌可以预防 25% 的所有肺炎、18% 的所有其他感染以及 65% 的严重感染。